Physician profile
Willscott E Naugler
NPI 1689698342
$5,651.76
in general payments reported to CMS, 2019-2025
8 companies · $691 in 2025
The $691 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2021: $2,580 · 2022: $58.77 · 2023: $68.79 · 2024: $2,066 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,483 · Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,482.50 |
| Food and Beverage | $342.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $2,580.00 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $1,477.19 | 2024 | Imfinzi |
| Cook Incorporated | $1,140.00 | 2024-2025 | Rosch-Uchida |
| Astellas Pharma US INC | $146.25 | 2022-2024 | Xtandi |
| Novo Nordisk INC | $120.54 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $99.54 | 2019 | |
| Biocompatibles, INC. | $88.24 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willscott Naugler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.